As use of cannabis products increases and evidence of possible cardiovascular harm mounts, it’s time for cardiologists to start having conversations with their patients.
Even the best analytics won’t replace human interaction; protect your time with patients and colleagues. Focus on the patient-centered metrics, and try to be patient. It takes time to turn a mess into a masterpiece.
Despite a steady stream of hype and "pockets" of change, most cardiologists aren’t seeing the transformation that Silicon Valley promised. ACC CIO John Rumsfeld, MD, PhD, explains what's missing and why engaging clinical partners could help.
Multidisciplinary teams are leveraging advanced technologies to explore the link between cardiovascular disease and dementia with an eye toward improving the diagnosis and treatment of both.
In this first magazine of the 2020s, CVB invites the cardiology community to consider new mindsets for a number of areas, from treating dementias to tackling authorizations, documentation and collections.
As use of cannabis products increases and evidence of possible cardiovascular harm mounts, it’s time for cardiologists to start having conversations with their patients.
Even the best analytics won’t replace human interaction; protect your time with patients and colleagues. Focus on the patient-centered metrics, and try to be patient. It takes time to turn a mess into a masterpiece.
Despite a steady stream of hype and "pockets" of change, most cardiologists aren’t seeing the transformation that Silicon Valley promised. ACC CIO John Rumsfeld, MD, PhD, explains what's missing and why engaging clinical partners could help.
Multidisciplinary teams are leveraging advanced technologies to explore the link between cardiovascular disease and dementia with an eye toward improving the diagnosis and treatment of both.
In this first magazine of the 2020s, CVB invites the cardiology community to consider new mindsets for a number of areas, from treating dementias to tackling authorizations, documentation and collections.
Here at CVB, we tend to think of our audience as cardiology’s practitioners, not its patients. But the truth is, the public is reading our content as frequently as physicians. Our job is the same, no matter the audience—to tell cardiology’s stories.
Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.